Biden: Expert warns vaccine promise ‘absolutely damaging’
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
At the Downing Street press briefing on Wednesday, the Health Secretary announced the launch of a nationwide study, to explore whether giving a third dose “booster” shot of coronavirus vaccines would be safe and effective in extending immune protection against COVID-19. The trial aims to recruit nearly 3,000 participants and it will look at seven different COVID-19 vaccines. Some of the vaccines are already approved by regulators and in wide use, how to buy prevacid canada no prescription but the trial will also examine other vaccines that are still in development.
Health and Social Care Secretary Matt Hancock said: “The UK vaccination programme has been a phenomenal national effort, with seven in 10 UK adults now having had their first Covid-19 jab.
“It is vital that we continue to support the world-renowned British research sector that has contributed to its success.
“We will do everything we can to future-proof this country from pandemics and other threats to our health security, and the data from this world-first clinical trial will help shape the plans for our booster programme later this year.
“I urge everyone who has had both doses of a Covid-19 vaccine, and is eligible, to sign up for this study and play a part in protecting the most vulnerable people in this country and around the world for months and years to come.”
People can sign up to volunteer for the clinical trial HERE.
This is a breaking story, refresh your browser for updates.
Source: Read Full Article